Biotech Values

[DewDiligence]

Sales projections for denosumab/Prolia/Xgeva are all over the map. Some analysts expect peak annual sales in all indications to amount to a mere $2B, while others foresee peak sales of $12B or more. The latter figure would likely make denosumab the largest-selling drug of all time.